Thomas Triomphe

Executive Vice President, Vaccines; responsibility for China · Sanofi

Pharmaceuticals

Thomas Triomphe is Sanofi’s executive vice president for Vaccines and also holds responsibility for China, following vaccine-franchise and Asia-Pacific leadership.

Last reviewed: Nov 15, 2026

Thomas Triomphe

Executive Summary

Thomas Triomphe is Sanofi’s executive vice president for Vaccines and also holds responsibility for China, following vaccine-franchise and Asia-Pacific leadership.

Career Highlights

  • Joined Sanofi’s vaccines business in 2004.
  • Led Vaccines Japan and then Asia-Pacific operations.
  • Became executive vice president for Vaccines in June 2020.

Professional Journey

Triomphe worked in banking and strategy consulting before joining Sanofi’s vaccines business in 2004. He advanced through sales, marketing and business-management assignments at country, regional and global levels.

After three years as director of the Influenza-Pneumo franchise in the United States, he became its associate vice president and head in 2010. He then led Vaccines Japan from 2012 to 2015 and the Asia-Pacific region, based in Singapore, from 2015 to 2018.

In January 2018, Triomphe became vice president and head of Franchise & Product Strategy for Vaccines. His work linked vaccine-franchise strategy with Manufacturing & Supply and R&D and included implementation of the business’s global brand model and roadmap.

He became executive vice president for Vaccines on June 15, 2020. In September 2026, Sanofi added responsibility for China to his vaccines remit. The combined role follows a career encompassing individual vaccine franchises, national operations, regional management and global product strategy.

Education

Triomphe holds an MSc in industrial engineering from École des Ponts ParisTech and IFP School and an MBA from INSEAD.